Barbara Melotti

5PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 14, 2026
Clinical significance of EGFR amplification in patients with EGFR-mutated metastatic non-small cell lung cancer receiving first-line osimertinib.

|Dec 11, 2025
Toward Personalized Response Monitoring in Melanoma Patients Treated with Immunotherapy and Target Therapy.

Federico Venturi, Elisabetta Magnaterra, Alberto Gualandi

|Jun 13, 2025
Efficacy and Safety of TROP-2-Targeting Antibody-Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient Data.

Sara Stumpo, Andrea Carlini, Francesco Mantuano

|Dec 17, 2024
Retrospective-Prospective Observational Study of Italian Patients Treated in Melanoma Adjuvant Cohort MAP-MADAM (Maximing ADjuvAnt MAP): Interim Analysis.

Francesca Consoli, Marco Tucci, Jacopo Pigozzo

|Jul 27, 2022
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes.

Alessandro Di Federico, Andrea De Giglio, Francesco Gelsomino

Pageof 1

Frequent Collaborators

3 joint publications

Alessandro Di Federico

3 joint publications

Andrea De Giglio

2 joint publications

Francesco Gelsomino

2 joint publications

Dario De Biase